Advisor Group Holdings »

Actuate Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.4k 1.0k 8.44
2025-06-30 $6.1k 1.0k 6.11

More positions owned by Advisor Group Holdings

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Spdr Series Trust Portfolio S&p500 (SPLG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Technology (XLK)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Advisor Group Holdings

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Geode Capital Management
Northern Trust
State Street Corporation
Northwestern Mutual Wealth Management Company
Gleason Group
SFMG Wealth Advisors
LPL Financial
Charles Schwab Investment Management
Wells Fargo & Company
Royal Bank of Canada
Freestone Capital Holdings

View all funds holding Actuate Therapeutics